Many chronic conditions such as arthritis or diabetes carry a risk of recurrence, even after years of successful medical management. In a similar way, there will always be a possibility of relapse for those in recovery.1 However, finding a reputable treatment program that utilizes evidence-based treatment (and staying in treatment long enough—NIDA recommends at least 3 months) gives people a head start on sobriety and gives them the tools they'll need to prevent relapse.2 Drug Rehab Near Me
Group, individual, and can help to address the root causes of addiction and build communication and life skills that are necessary to live a sober life. Group therapy and family therapy provide a means to talk openly and honestly about your addiction and gain support from other in recovery, parents, siblings and adult children. One-on-one talk therapy provides the opportunity to more deeply explore underlying issues and trauma in a private setting.
According to the National Institute on Drug Abuse, addiction is a "chronic, relapsing brain disease that is characterized by compulsive drug seeking and use, despite harmful consequences."7 There is no simple cure for addiction; however, effective treatment can help you become and stay sober.7 You will have to manage your addiction throughout your life, the same way a diabetic has to manage their condition with ongoing efforts like a proper diet and exercise.8
Group therapy tends to involve a licensed professional and multiple patients. Although group therapy sessions can occur at inpatient facilities, they are more likely to happen in the other rehabilitation programs. Group therapy sessions can last up to an hour. These sessions tend to be particularly useful because they help confront one of the primary issues of addiction. Drug Rehab Arizona | Best Drug Rehab Arizona Information
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval. From Rehab to a Body Bag | Dying for Treatment: VICE Reports (Full Length)